Summing up, heparin might exert beneficial effects on atherosclerotic lesion formation by blocking CXCL12 and CXCL4, but the induction of atherogenic leukocytosis might counter-balance these positive effects and additionally impede healing processes after myocardial infarction. The gene discussed is CXCL12; the disease is myocardial infarction.